CRT 2026
Heart Failure
Cynthia Bither, NP
NP, Advanced Heart Failure Program
MedStar Washington Hospital Center
Shady Side, Maryland, United States
Disclosure information not submitted.
Nisha Gilotra, MD
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Disclosure information not submitted.
Mark R. Hofmeyer, MD, FACC
Attending Physician - Advanced Heart Failure
Associate Professor - Georgetown University School of Medicine
MedStar Health
Washington, District of Columbia, United States
Disclosure information not submitted.
Daniele Massera, MD, MSc
Associate Director, Hypertrophic Cardiomyopathy Program
NYU Langone Health
New York, New York, United States
Disclosure(s): Chiesi Inc: Consulting Fees (e.g., advisory boards) (Terminated, April 30, 2025); Cytokinetics: Consulting Fees (e.g., advisory boards) (Terminated); Rocket Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); Sanofi: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Patrick T. Bering, MD
Cardiologist, Medical Director of Hypertrophic Cardiomyopathy
MedStar Washington Hospital Center
GLENELG, Maryland, United States
Disclosure information not submitted.
Cyrus A. Hadadi, MD
Associate Director of Cardiac Arrhythmia Research
MedStar Heart & Vascular Institute
Washington, District of Columbia, United States
Disclosure information not submitted.
Marysa Leya, MD
Disclosure(s): No financial relationships to disclose
Thomas E. MacGillivray, MD
Physician Executive Director and Chair, Cardiac Surgery
MedStar Health, MedStar Washington Hospital Center
Washington, District of Columbia, United States
Disclosure information not submitted.
Stephane Rinfret, MD, SM
Director of Complex Coronary Interventions
Georgia Heart Institute
Gainesville, Georgia, United States
Disclosure information not submitted.
Maurice Sarano, MD
Senior Scientist
Minneapolis Heart Institute
Minneapolis, Minnesota, United States
Disclosure(s): HighLifeSAS: Consulting Fees (e.g., advisory boards) (Ongoing)